{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:50:10Z","timestamp":1790913010490,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"S1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Filaria J"],"DOI":"10.1186\/1475-2883-2-s1-s8","type":"journal-article","created":{"date-parts":[[2003,10,25]],"date-time":"2003-10-25T20:18:04Z","timestamp":1067113084000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["Ivermectin: does P-glycoprotein play a role in neurotoxicity?"],"prefix":"10.1186","volume":"2","author":[{"given":"Geoffrey","family":"Edwards","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,10,24]]},"reference":[{"key":"25_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S0140-6736(96)11094-1","volume":"350","author":"J Gardon","year":"1997","unstructured":"Gardon J, Gardon-Wendel N, Demanga-Ngangue , Kamgno J, Chippaux JP, Boussinesq M: Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet. 1997, 350: 18-22. 10.1016\/S0140-6736(96)11094-1.","journal-title":"Lancet"},{"key":"25_CR2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4269\/ajtmh.1998.58.461","volume":"58","author":"M Boussinesq","year":"1998","unstructured":"Boussinesq M, Gardon J, Gardon-Wendel N, Kamgno J, Ngoumou P, Chippaux JP: Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis. Am J Trop Med Hyg. 1998, 58: 461-469.","journal-title":"Am J Trop Med Hyg"},{"key":"25_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/978-1-4612-3626-9_2","volume-title":"In: Ivermectin and Ababmectin","author":"RW Burg","year":"1989","unstructured":"Burg RW, Stapley EO: Isolation and characterisation of the producing organism. In: Ivermectin and Ababmectin. Edited by: William C Campbell. 1989, New York, Berlin, Heidelberg, London, Paris, Tokyo, Springer-Verlag, 24-32."},{"key":"25_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4612-3626-9_1","volume-title":"In: Ivermectin and Ababmectin","author":"MH Fisher","year":"1989","unstructured":"Fisher MH, Mrozik H: Chemistry. In: Ivermectin and Ababmectin. Edited by: William C Campbell. 1989, New York, Berlin, Heidelberg, London, Paris, Tokyo, Springer-Verlag, 1-23."},{"key":"25_CR5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1006\/expr.1993.1064","volume":"77","author":"TG Geary","year":"1993","unstructured":"Geary TG, Sims SM, Thomas EM, Vanover L, Davis JP, Winterrowd CA, Klein RD, Ho NF, Thompson DP: Haemonchus contortus: ivermectin-induced paralysis of the pharynx. Exp Parasitol. 1993, 77: 88-96. 10.1006\/expr.1993.1064.","journal-title":"Exp Parasitol"},{"key":"25_CR6","first-page":"587","volume":"120","author":"RJ Martin","year":"1996","unstructured":"Martin RJ: An electrophysiological preparation of pharyngeal muscle reveals a glutamate-gated chloride channel sensitive to the avermectin analogue milbemycin D. Parasitology. 1996, 120: 587-594.","journal-title":"Parasitology"},{"key":"25_CR7","doi-asserted-by":"publisher","first-page":"E631","DOI":"10.2307\/3284740","volume":"84","author":"AC Kotze","year":"1998","unstructured":"Kotze AC: ffects of macrocyclic lactones on ingestion in susceptible and resistant Haemonchus contortus larvae. J Parasitol. 1998, 84: E631-635. 10.2307\/3284740.","journal-title":"J Parasitol"},{"key":"25_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0169-4758(99)01413-1","volume":"15","author":"NC Sangster","year":"1999","unstructured":"Sangster NC, Gill J: Pharmacology of anthelmintic resistance. Parasitol Today. 1999, 15: 141-146. 10.1016\/S0169-4758(99)01413-1.","journal-title":"Parasitol Today"},{"key":"25_CR9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1017\/S0031182000077970","volume":"113","author":"DF Cully","year":"1996","unstructured":"Cully DF, Wilkinson H, Vassilatis DK, Etter A, Arena JP: Molecular biology and electrophysiology of glutamate-gated chloride channels of invertebrates. Parasitology. 1996, 113: 191-200. 10.1017\/S0031182000077970.","journal-title":"Parasitology"},{"key":"25_CR10","doi-asserted-by":"publisher","first-page":"5867","DOI":"10.1093\/emboj\/16.19.5867","volume":"16","author":"JA Dent","year":"1997","unstructured":"Dent JA, Davis MW, Avery L: avr-15 encodes a chloride channel subunit that mediates inhibitory glutaminergic neurotransmission and ivermectin sensitivity in Caenorhabditis elegans. EMBO J. 1997, 16: 5867-5879. 10.1093\/emboj\/16.19.5867.","journal-title":"EMBO J"},{"key":"25_CR11","doi-asserted-by":"publisher","first-page":"33167","DOI":"10.1074\/jbc.272.52.33167","volume":"272","author":"DK Vassilatis","year":"1997","unstructured":"Vassilatis DK, Arena JP, Plasterk RHA, Wilkinson HA, Schaeffer JM, Cully DF, Van der Ploeg LHT: Genetic and biochemical evidence for a novel avermectin sensitive chloride channel in Caenorhabditis elegans. J Biol Chem. 1997, 272: 33167-33174. 10.1074\/jbc.272.52.33167.","journal-title":"J Biol Chem"},{"key":"25_CR12","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/S0020-7519(01)00131-X","volume":"31","author":"P Kohler","year":"2001","unstructured":"Kohler P: The biochemical basis of anthelmintics resistance. Int J Parasitol. 2001, 31: 336-345. 10.1016\/S0020-7519(01)00131-X.","journal-title":"Int J Parasitol"},{"key":"25_CR13","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/jnc.1999.72.1.318","volume":"72","author":"A Etter","year":"1999","unstructured":"Etter A, Cully DF, Liu KK, Reiss B, Vassilatis DK, Schaeffer JM, Arena JP: Picrotoxin blockade of invertebrate glutamate gated chloride channels: subunit dependence and evidence for binding within the pore. J Neurochem. 1999, 72: 318-326.","journal-title":"J Neurochem"},{"key":"25_CR14","first-page":"581","volume":"27","author":"GY Kwei","year":"1999","unstructured":"Kwei GY, Alvaro RF, Chen Q, Jenkins HJ, Hop CEAC, Keohane CA, Ly VT, Strauss JR, Wang RW, Wang Z, et al: Disposition of ivermectin and cyclosporin A in CF-1 mice deficient in MDR1A p-glycoprotein. Drug Metab Dispos. 1999, 27: 581-587.","journal-title":"Drug Metab Dispos"},{"key":"25_CR15","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1002\/1520-6017(200011)89:11<1371::AID-JPS1>3.0.CO;2-D","volume":"89","author":"I Tamai","year":"2000","unstructured":"Tamai I, Atsuji A: Transporter-mediated permeation of drugs across the blood brain barrier. J Pharm Sci. 2000, 89: 1371-1388. 10.1002\/1520-6017(200011)89:11<1371::AID-JPS1>3.0.CO;2-D.","journal-title":"J Pharm Sci"},{"key":"25_CR16","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1080\/00498250110060969","volume":"31","author":"A Ayrton","year":"2001","unstructured":"Ayrton A, Morgan P: Role of transport proteins in drug absorption, distribution and excretion. Xenobiotica. 2001, 31: 469-497. 10.1080\/00498250110060969.","journal-title":"Xenobiotica"},{"key":"25_CR17","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1073\/pnas.86.2.695","volume":"86","author":"C Cordon-Cardo","year":"1989","unstructured":"Cordon-Cardo C, O'Brien JP, Casals D, Rittman Graver L, Beidler JL, Melamed MR, Bertino JR: Multidrug resistance gene P-glycoprotein is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA. 1989, 86: 695-698. 10.1073\/pnas.86.2.695.","journal-title":"Proc Natl Acad Sci USA"},{"key":"25_CR18","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1006\/bbrc.1997.8132","volume":"243","author":"H Huai-Yun","year":"1998","unstructured":"Huai-Yun H, Secrest DT, Mark KS, Carney D, Brandquist C, Elmquist WF, Miller DW: Expression of multidrug resistance-assocaited protein (MRP) in brain microvessel endothelial cells. Biochem Biophys Res Comm. 1998, 243: 816-820. 10.1006\/bbrc.1997.8132.","journal-title":"Biochem Biophys Res Comm"},{"key":"25_CR19","first-page":"1260","volume":"285","author":"H Kusuhara","year":"1998","unstructured":"Kusuhara H, Suzuki H, Naito M, Tsuro T, Sugiyama Y: Characterisation of efflux transport of organic anions in a mouse brain capillary endothelial cell line. J Pharm Exp Ther. 1998, 285: 1260-1265.","journal-title":"J Pharm Exp Ther"},{"key":"25_CR20","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1177\/002215549904701005","volume":"47","author":"B Gao","year":"1999","unstructured":"Gao B, Steiger B, Noe B, Fritschy JM, Meier PJ: Localisation of the organic anion transporting polypeptide 2 (Oatp 2) in capillary endothelium and choroids plexus epithelium of rat brain. J Histochem Cytochem. 1999, 47: 1255-1263. 10.1177\/002215549904701005.","journal-title":"J Histochem Cytochem"},{"key":"25_CR21","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1073\/pnas.97.7.3473","volume":"97","author":"S Hoffmeyer","year":"2000","unstructured":"Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmoller J, Johne A, Cascorbi L, Gerlo T, Roots I, Eichelbaum M, Brinkmann U: Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA. 2000, 97: 3473-3478. 10.1073\/pnas.050585397.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"suppl 2","key":"25_CR22","first-page":"199","volume":"32","author":"RB Kim","year":"2000","unstructured":"Kim RB, Leake B, Choo E, Dresser GK, Kubra SV, Schwarz UL, Taylor A, Xie HG, Stein CM, Wood AJJ, et al: Identification of functionally important MDR1 variant alleles among African-American and Caucasian subjects. Drug Metab Rev. 2000, 32 (suppl 2): 199-","journal-title":"Drug Metab Rev"},{"key":"25_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/978-1-4612-3626-9_6","volume-title":"In: Ivermectin and Ababmectin","author":"GR Lankas","year":"1989","unstructured":"Lankas GR, Gordon LR: Toxicology. In: Ivermectin and Ababmectin. Edited by: William C Campbell. 1989, New York, Berlin, Heidelberg, London, Paris, Tokyo, Springer-Verlag, 89-112."},{"key":"25_CR24","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1080\/00034989859564","volume":"92","author":"KR Brown","year":"1998","unstructured":"Brown KR: Changes in the use profile of Mectizan\u00ae: 1987\u20131997. Ann Trop Med Parasitol. 1998, 92: S61-S64. 10.1080\/00034989859564.","journal-title":"Ann Trop Med Parasitol"},{"key":"25_CR25","first-page":"684","volume":"48","author":"AJ Paul","year":"1987","unstructured":"Paul AJ, Tranquilli WJ, Seward RL, Todd KS, DiPietro JA: Clinical observations in collies given ivermectin orally. Am J Vet Res. 1987, 48: 684-685.","journal-title":"Am J Vet Res"},{"key":"25_CR26","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1097\/00008571-200111000-00012","volume":"11","author":"KL Mealey","year":"2001","unstructured":"Mealey KL, Bentjen SA, Gay JM, Cantor GH: Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenetics. 2001, 11: 727-733. 10.1097\/00008571-200111000-00012.","journal-title":"Pharmacogenetics"},{"key":"25_CR27","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1006\/taap.1997.8225","volume":"146","author":"DR Umbenhauer","year":"1997","unstructured":"Umbenhauer DR, Lankas GR, Pippert TR, Wise LD, Cartwright ME, Hall SJ, Beare CM: Identification of a P-glycoprotein-deficient subpopulation in the CF-1 mouse strain using a restriction fragment length polymorphism. Toxicol Applied Pharmacol. 1997, 146: 88-94. 10.1006\/taap.1997.8225.","journal-title":"Toxicol Applied Pharmacol"},{"key":"25_CR28","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/0092-8674(94)90212-7","volume":"77","author":"AH Schinkel","year":"1994","unstructured":"Schinkel AH, Smit JJ, van Tellingen O, Beijen JH, Wagenaar E, van Deemter L, Mol CAAM, van der Valk MA, Robanus Maandag EC, Borst F: Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell. 1994, 77: 491-502. 10.1016\/0092-8674(94)90212-7.","journal-title":"Cell"},{"key":"25_CR29","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1172\/JCI118214","volume":"96","author":"AH Schinkel","year":"1995","unstructured":"Schinkel AH, Wagenaar E, van Deemter L, Mol CAAM, Borst F: Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin and cyclosporin A. J Clin Invest. 1995, 96: 1698-1705. 10.1172\/JCI118214.","journal-title":"J Clin Invest"},{"key":"25_CR30","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1073\/pnas.94.5.2031","volume":"94","author":"A Sparreboom","year":"1997","unstructured":"Sparreboom A, van Asperen J, Mayer U, Schinkel AH, Smit JW, Meier DKF, Borst P, Nooijen WJ, Beinen JH, van Tellingen O: Limited oral bioavailability and active epithelial secretion of paclitaxel (taxol) caused by P-glycoprotein in the intestine. Proc Natl Acad Sci USA. 1997, 94: 2013-2035. 10.1073\/pnas.94.5.2031.","journal-title":"Proc Natl Acad Sci USA"},{"key":"25_CR31","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.1017\/S0031182000007423","volume":"121: Suppl","author":"J Horton","year":"2000","unstructured":"Horton J, Witt C, Ottesen EA, Lazdins JK, Addiss DG, Awadzi K, Beach MJ, Belizario VY, Dunyo SK, Espinel M, et al: An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis. Parasitology. 2000, 121: Suppl: S147-160. 10.1017\/S0031182000007423.","journal-title":"Parasitology"},{"key":"25_CR32","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1046\/j.1365-2125.2000.00170.x","volume":"49","author":"HC Rawden","year":"2000","unstructured":"Rawden HC, Kokwaro GO, Ward SA, Edwards G: Relative contribution of cytochromes P-450 and flavin-containing monoxygenases to the metabolism of albendazole by human liver microsomes. Br J Clin Pharmacol. 2000, 49: 313-322. 10.1046\/j.1365-2125.2000.00170.x.","journal-title":"Br J Clin Pharmacol"},{"key":"25_CR33","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/004982598239597","volume":"28","author":"Zeng","year":"1998","unstructured":"Zeng , Andrew NW, Arison BH, Luffer-Atlas D, Wang RW: Identification of P4503A4 as the major enzyme responsible for the metabolism of ivermectin by human liver microsomes. Xenobiotica. 1998, 28: 313-321. 10.1080\/004982598239597.","journal-title":"Xenobiotica"},{"key":"25_CR34","volume-title":"The University of Liverpool","author":"HC Rawden","year":"1999","unstructured":"Rawden HC: Ph.D. thesis. \"An investigation of potential chemotherapeutic drug combinations with Albendazole for the treatment of Echinococcus infection\". The University of Liverpool. 1999"},{"key":"25_CR35","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/sj.bjp.0703762","volume":"132","author":"S Nobmann","year":"2001","unstructured":"Nobmann S, Bauer B, Fricker G: Ivermectin excretion by isolated functionally intact brain endothelial capillaries. Br J Pharmacol. 2001, 132: 722-728. 10.1038\/sj.bjp.0703762.","journal-title":"Br J Pharmacol"},{"key":"25_CR36","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1023\/A:1018956621376","volume":"16","author":"G Fricker","year":"1999","unstructured":"Fricker G, Gutmann H, Droulle A, Drewe J, Miller DS: Epithelial transport of anthelmintic ivermectin in a novel model of isolated proximal kidney tubules. Pharm Res. 1999, 16: 1570-1575. 10.1023\/A:1018956621376.","journal-title":"Pharm Res"},{"key":"25_CR37","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0006-2952(99)00026-X","volume":"15","author":"J Drewe","year":"1999","unstructured":"Drewe J, Gutmann H, Fricker G, Torok M, Beglinger C, Huwyler J: HIV protease inhibitor ritonavir: a more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833. Biochem Pharmacol. 1999, 15: 1147-1152. 10.1016\/S0006-2952(99)00026-X.","journal-title":"Biochem Pharmacol"},{"key":"25_CR38","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1124\/mol.56.2.383","volume":"56","author":"H Gutmann","year":"1999","unstructured":"Gutmann H, Fricker G, Drewe J, Toeroek M, Miller DS: Interactions of HIV protease inhibitors with ATP-dependent drug export proteins. Mol Pharm. 1999, 56: 383-389.","journal-title":"Mol Pharm"},{"key":"25_CR39","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1600-0773.1999.tb00887.x","volume":"84","author":"LF Marques-Santos","year":"1999","unstructured":"Marques-Santos LF, Bernardo RR, de Paula EF, Rumjanek VM: Cyclosporin A and trifluperazine, two resistance modulating agents, increase ivermectin neurotoxicity in mice. Pharmacol Toxicol. 1999, 84: 125-129. 10.1111\/j.1600-0773.1999.tb00887.x.","journal-title":"Pharmacol Toxicol"},{"key":"25_CR40","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/0006-2952(94)00427-7","volume":"48","author":"B Nare","year":"1994","unstructured":"Nare B, Liu Z, Prichard RK, Georges EE: Benzimidazoles, potent anti-mitotic drugs: substrates for the P-glycoprotein transporter in multidrug-resistant cells. Biochem Pharmacol. 1994, 48: 2215-2222. 10.1016\/0006-2952(94)00427-7.","journal-title":"Biochem Pharmacol"},{"key":"25_CR41","first-page":"736","volume":"27","author":"PA Redondo","year":"1999","unstructured":"Redondo PA, Alvarez AI, Garcia JL, Larrode OM, Merino G, Prieto JG: Presystemic metabolism of albendazole: experimental evidence of an efflux process of albendazole sulphoxide to intestinal lumen. Drug Metab Dispos. 1999, 27: 736-740.","journal-title":"Drug Metab Dispos"},{"key":"25_CR42","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1124\/dmd.30.4.365","volume":"30","author":"G Merino","year":"2002","unstructured":"Merino G, Alvarez AJ, Prieto JG, Kim RB: The anthelmintic agent albendazole does not interact with p-glycoprotein. Drug Metab Dispos. 2002, 30: 365-369. 10.1124\/dmd.30.4.365.","journal-title":"Drug Metab Dispos"},{"key":"25_CR43","first-page":"1276","volume":"295","author":"S Ibrahim","year":"2000","unstructured":"Ibrahim S, Peggins J, Knapton A, Licht T, Aszalos A: Influence of antipsychotic, antiemetic and Ca2+ channel blocker drugs on the cellular accumulation of the anticancer drug daunorubicin: P-glycoprotein modulation. J Pharm Exp Ther. 2000, 295: 1276-1283.","journal-title":"J Pharm Exp Ther"},{"key":"25_CR44","doi-asserted-by":"crossref","first-page":"684","DOI":"10.4269\/ajtmh.1991.44.684","volume":"44","author":"B Carme","year":"1991","unstructured":"Carme B, Boulesteix J, Boutes H, Puruehnce MF: Five cases of encephalitis during treatment of loaiasis with diethylcarbamazine. Am J Trop Med Hyg. 1991, 44: 684-690.","journal-title":"Am J Trop Med Hyg"}],"container-title":["Filaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2883-2-S1-S8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T11:24:38Z","timestamp":1726226678000},"score":1,"resource":{"primary":{"URL":"https:\/\/filariajournal.biomedcentral.com\/articles\/10.1186\/1475-2883-2-S1-S8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10,24]]},"references-count":44,"journal-issue":{"issue":"S1","published-online":{"date-parts":[[2003,10]]}},"alternative-id":["25"],"URL":"https:\/\/doi.org\/10.1186\/1475-2883-2-s1-s8","relation":{},"ISSN":["1475-2883"],"issn-type":[{"value":"1475-2883","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10,24]]},"assertion":[{"value":"24 October 2003","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"S8"}}